Pradeep Sanghvi

Former Director-Formulations & Process Development at Penwest Pharmaceuticals Co.

Pradeep Sanghvi

Pradeep Sanghvi

Former Director-Formulations & Process Development at Penwest Pharmaceuticals Co.

Biography

Pradeep Sanghvi has been Vice President of Pharmaceutical Development for MonoSol Rx, Inc. since 2004. Prior to joining MonoSol Rx, he was Director of Pharmaceutical Development for Penwest Pharmaceuticals from October, 2000 to February, 2004 and Director of Formulations and Process Development for Fuisz Technologies from December, 1994 to September, 2000.

Overview
RelSci Relationships

54

Birthday

1965

Age

53

Relationships
RelSci Relationships are individuals Pradeep Sanghvi likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Vice President-Business Development at Corium International, Inc.

Relationship likelihood: Average

Former Director-Infrastructure Services at Hoffmann-La Roche, Inc.

Relationship likelihood: Average

Co-Founder at Trevi Therapeutics, Inc.

Relationship likelihood: Average

President at Sun Valley Center for the Arts

Relationship likelihood: Average

Chief Executive Officer at Izun Pharmaceuticals Corp.

Relationship likelihood: Average

Former Chief Scientific Officer & Senior Vice President at Penwest Pharmaceuticals Co.

Relationship likelihood: Average

Controller at Trevi Therapeutics, Inc.

Relationship likelihood: Average

Co-Founder at Trevi Therapeutics, Inc.

Relationship likelihood: Average

Chief Executive Officer & Director at Bimeda Holdings Plc

Relationship likelihood: Average

Chief Financial Officer & Secretary at Sonoma Pharmaceuticals, Inc.

Relationship likelihood: Average

Paths to Pradeep Sanghvi
Potential Connections via
Relationship Science
You
Pradeep Sanghvi
Former Director-Formulations & Process Development at Penwest Pharmaceuticals Co.
Career History
Vice President-Pharmaceutical Development
2004 - Prior

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying, developing, and commercializing differentiated products to address unmet medical needs. The company has a late-stage proprietary product pipeline focused on the treatment of Central nervous system (CNS) diseases, as well as orally-administered complex molecules that can be alternatives to invasively-administered standard of care therapies. Its product candidates include Libervant, Sympazan, and AQST-117 (Riluzole). Aquestive Therapeutics develops and delivers drugs via its PharmFilm® technology. The company also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms. In addition to its proprietary product candidates, the company, with its partners, has a portfolio of development-stage products and commercialized products, such as Suboxone, a prescription medicine for the treatment of opioid dependence. The company was founded in January 2004 and is headquartered in Warren, NJ.

Director-Formulations & Process Development
2000 - 2004

Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY.

Director-Formulations & Process Development
1994 - 2000

Part of Bausch Health Cos., Inc., Fuisz Technologies Ltd is a company headquartered in Chantilly, VA, that develops and commercializes rapid dissolving tablets for over-the-counter and prescription pharmaceuticals. It was acquired by Biovail Corp. on 12 Nov 99 for $145.48 million.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pradeep Sanghvi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pradeep Sanghvi's profile does not indicate a business or promotional relationship of any kind between RelSci and Pradeep Sanghvi.